FDA approves new COVID-19 shots
The Food and Drug Administration approved updated COVID-19 vaccines on Thursday for people at higher risk, clearing the way for manufacturers to begin shipping them to pharmacies and physicians' offices. The agency greenlit new formulations of the mRNA vaccines from Pfizer-BioNTech and Moderna, the companies said. FDA also approved a non-mRNA shot from Sanofi, which...
Covered in this story
What has happened since
- Moderna is up 69.6% since this was published, 54 days ago.
- Sanofi is down 5.2% since this was published, 54 days ago.
- Pfizer is up 7.5% since this was published, 54 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Moderna
- Citi: $193 → $80 by Sep 2027 · Sell via 247wallst.com
- Rothschild & Co Redburn: $149 → $81 by Sep 2027 · Sell via Investing.com
- Morgan Stanley: $174 → $89 by Aug 2027 · Equalweight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MRNA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Moderna →Summary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.